- REPORT SUMMARY
- TABLE OF CONTENTS
-
Choroidal neovascularization describes the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub–retinal pigment epithelium (sub-RPE) or subretinal space.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Choroidal Neovascularization market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Choroidal Neovascularization market. Detailed analysis of key players, along with key growth strategies adopted by Choroidal Neovascularization industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
QLT Inc
Valeant Pharmaceuticals International Inc
Promedior Inc
F Hoffmann-La Roche Ltd
Novartis AG
Sanwa Kagaku Kenkyusho Co Ltd
Regeneron Pharmaceuticals Inc
Bayer AG
Pfizer Inc
Gilead Sciences Inc
By Type:
Intravenous
Intravitreal
By End-User:
Extreme Myopia
Malignant Myopic Degeneration
Age-related Developments
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Choroidal Neovascularization Market
-
1.3 Market Segment by Type
-
1.3.1 USA Choroidal Neovascularization Market Size and Growth Rate of Intravenous from 2016 to 2027
-
1.3.2 USA Choroidal Neovascularization Market Size and Growth Rate of Intravitreal from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Choroidal Neovascularization Market Size and Growth Rate of Extreme Myopia from 2016 to 2027
-
1.4.2 USA Choroidal Neovascularization Market Size and Growth Rate of Malignant Myopic Degeneration from 2016 to 2027
-
1.4.3 USA Choroidal Neovascularization Market Size and Growth Rate of Age-related Developments from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Choroidal Neovascularization Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Choroidal Neovascularization Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Choroidal Neovascularization Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Choroidal Neovascularization Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Choroidal Neovascularization Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Choroidal Neovascularization by Major Types
-
3.4.1 Market Size and Growth Rate of Intravenous
-
3.4.2 Market Size and Growth Rate of Intravitreal
4 Segmentation of Choroidal Neovascularization Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Choroidal Neovascularization by Major End-Users
-
4.4.1 Market Size and Growth Rate of Choroidal Neovascularization in Extreme Myopia
-
4.4.2 Market Size and Growth Rate of Choroidal Neovascularization in Malignant Myopic Degeneration
-
4.4.3 Market Size and Growth Rate of Choroidal Neovascularization in Age-related Developments
5 Market Analysis by Regions
-
5.1 USA Choroidal Neovascularization Production Analysis by Regions
-
5.2 USA Choroidal Neovascularization Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Choroidal Neovascularization Landscape Analysis
-
6.1 West USA Choroidal Neovascularization Landscape Analysis by Major Types
-
6.2 West USA Choroidal Neovascularization Landscape Analysis by Major End-Users
7 South USA Choroidal Neovascularization Landscape Analysis
-
7.1 South USA Choroidal Neovascularization Landscape Analysis by Major Types
-
7.2 South USA Choroidal Neovascularization Landscape Analysis by Major End-Users
8 Middle West USA Choroidal Neovascularization Landscape Analysis
-
8.1 Middle West USA Choroidal Neovascularization Landscape Analysis by Major Types
-
8.2 Middle West USA Choroidal Neovascularization Landscape Analysis by Major End-Users
9 Northeast USA Choroidal Neovascularization Landscape Analysis
-
9.1 Northeast USA Choroidal Neovascularization Landscape Analysis by Major Types
-
9.2 Northeast USA Choroidal Neovascularization Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 QLT Inc
-
10.1.1 QLT Inc Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Valeant Pharmaceuticals International Inc
-
10.2.1 Valeant Pharmaceuticals International Inc Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Promedior Inc
-
10.3.1 Promedior Inc Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 F Hoffmann-La Roche Ltd
-
10.4.1 F Hoffmann-La Roche Ltd Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Novartis AG
-
10.5.1 Novartis AG Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Sanwa Kagaku Kenkyusho Co Ltd
-
10.6.1 Sanwa Kagaku Kenkyusho Co Ltd Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Regeneron Pharmaceuticals Inc
-
10.7.1 Regeneron Pharmaceuticals Inc Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Bayer AG
-
10.8.1 Bayer AG Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Pfizer Inc
-
10.9.1 Pfizer Inc Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Gilead Sciences Inc
-
10.10.1 Gilead Sciences Inc Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Choroidal Neovascularization Market Size and Growth Rate of Intravenous from 2016 to 2027
-
Figure USA Choroidal Neovascularization Market Size and Growth Rate of Intravitreal from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Choroidal Neovascularization Market Size and Growth Rate of Extreme Myopia from 2016 to 2027
-
Figure USA Choroidal Neovascularization Market Size and Growth Rate of Malignant Myopic Degeneration from 2016 to 2027
-
Figure USA Choroidal Neovascularization Market Size and Growth Rate of Age-related Developments from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Choroidal Neovascularization Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Choroidal Neovascularization Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Choroidal Neovascularization Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Choroidal Neovascularization Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Choroidal Neovascularization Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Choroidal Neovascularization
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Choroidal Neovascularization by Different Types from 2016 to 2027
-
Table Consumption Share of Choroidal Neovascularization by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Intravenous
-
Figure Market Size and Growth Rate of Intravitreal
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Choroidal Neovascularization by Different End-Users from 2016 to 2027
-
Table Consumption Share of Choroidal Neovascularization by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Extreme Myopia
-
Figure Market Size and Growth Rate of Malignant Myopic Degeneration
-
Figure Market Size and Growth Rate of Age-related Developments
-
Table USA Choroidal Neovascularization Production by Regions
-
Table USA Choroidal Neovascularization Production Share by Regions
-
Figure USA Choroidal Neovascularization Production Share by Regions in 2016
-
Figure USA Choroidal Neovascularization Production Share by Regions in 2021
-
Figure USA Choroidal Neovascularization Production Share by Regions in 2027
-
Table USA Choroidal Neovascularization Consumption by Regions
-
Table USA Choroidal Neovascularization Consumption Share by Regions
-
Figure USA Choroidal Neovascularization Consumption Share by Regions in 2016
-
Figure USA Choroidal Neovascularization Consumption Share by Regions in 2021
-
Figure USA Choroidal Neovascularization Consumption Share by Regions in 2027
-
Table West USA Choroidal Neovascularization Consumption by Types from 2016 to 2027
-
Table West USA Choroidal Neovascularization Consumption Share by Types from 2016 to 2027
-
Figure West USA Choroidal Neovascularization Consumption Share by Types in 2016
-
Figure West USA Choroidal Neovascularization Consumption Share by Types in 2021
-
Figure West USA Choroidal Neovascularization Consumption Share by Types in 2027
-
Table West USA Choroidal Neovascularization Consumption by End-Users from 2016 to 2027
-
Table West USA Choroidal Neovascularization Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Choroidal Neovascularization Consumption Share by End-Users in 2016
-
Figure West USA Choroidal Neovascularization Consumption Share by End-Users in 2021
-
Figure West USA Choroidal Neovascularization Consumption Share by End-Users in 2027
-
Table South USA Choroidal Neovascularization Consumption by Types from 2016 to 2027
-
Table South USA Choroidal Neovascularization Consumption Share by Types from 2016 to 2027
-
Figure South USA Choroidal Neovascularization Consumption Share by Types in 2016
-
Figure South USA Choroidal Neovascularization Consumption Share by Types in 2021
-
Figure South USA Choroidal Neovascularization Consumption Share by Types in 2027
-
Table South USA Choroidal Neovascularization Consumption by End-Users from 2016 to 2027
-
Table South USA Choroidal Neovascularization Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Choroidal Neovascularization Consumption Share by End-Users in 2016
-
Figure South USA Choroidal Neovascularization Consumption Share by End-Users in 2021
-
Figure South USA Choroidal Neovascularization Consumption Share by End-Users in 2027
-
Table Middle West USA Choroidal Neovascularization Consumption by Types from 2016 to 2027
-
Table Middle West USA Choroidal Neovascularization Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Choroidal Neovascularization Consumption Share by Types in 2016
-
Figure Middle West USA Choroidal Neovascularization Consumption Share by Types in 2021
-
Figure Middle West USA Choroidal Neovascularization Consumption Share by Types in 2027
-
Table Middle West USA Choroidal Neovascularization Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Choroidal Neovascularization Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Choroidal Neovascularization Consumption Share by End-Users in 2016
-
Figure Middle West USA Choroidal Neovascularization Consumption Share by End-Users in 2021
-
Figure Middle West USA Choroidal Neovascularization Consumption Share by End-Users in 2027
-
Table Northeast USA Choroidal Neovascularization Consumption by Types from 2016 to 2027
-
Table Northeast USA Choroidal Neovascularization Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Choroidal Neovascularization Consumption Share by Types in 2016
-
Figure Northeast USA Choroidal Neovascularization Consumption Share by Types in 2021
-
Figure Northeast USA Choroidal Neovascularization Consumption Share by Types in 2027
-
Table Northeast USA Choroidal Neovascularization Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Choroidal Neovascularization Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Choroidal Neovascularization Consumption Share by End-Users in 2016
-
Figure Northeast USA Choroidal Neovascularization Consumption Share by End-Users in 2021
-
Figure Northeast USA Choroidal Neovascularization Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of QLT Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of QLT Inc
-
Figure Sales and Growth Rate Analysis of QLT Inc
-
Figure Revenue and Market Share Analysis of QLT Inc
-
Table Product and Service Introduction of QLT Inc
-
Table Company Profile and Development Status of Valeant Pharmaceuticals International Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharmaceuticals International Inc
-
Figure Sales and Growth Rate Analysis of Valeant Pharmaceuticals International Inc
-
Figure Revenue and Market Share Analysis of Valeant Pharmaceuticals International Inc
-
Table Product and Service Introduction of Valeant Pharmaceuticals International Inc
-
Table Company Profile and Development Status of Promedior Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Promedior Inc
-
Figure Sales and Growth Rate Analysis of Promedior Inc
-
Figure Revenue and Market Share Analysis of Promedior Inc
-
Table Product and Service Introduction of Promedior Inc
-
Table Company Profile and Development Status of F Hoffmann-La Roche Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd
-
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd
-
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd
-
Table Product and Service Introduction of F Hoffmann-La Roche Ltd
-
Table Company Profile and Development Status of Novartis AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG
-
Figure Sales and Growth Rate Analysis of Novartis AG
-
Figure Revenue and Market Share Analysis of Novartis AG
-
Table Product and Service Introduction of Novartis AG
-
Table Company Profile and Development Status of Sanwa Kagaku Kenkyusho Co Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanwa Kagaku Kenkyusho Co Ltd
-
Figure Sales and Growth Rate Analysis of Sanwa Kagaku Kenkyusho Co Ltd
-
Figure Revenue and Market Share Analysis of Sanwa Kagaku Kenkyusho Co Ltd
-
Table Product and Service Introduction of Sanwa Kagaku Kenkyusho Co Ltd
-
Table Company Profile and Development Status of Regeneron Pharmaceuticals Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Regeneron Pharmaceuticals Inc
-
Figure Sales and Growth Rate Analysis of Regeneron Pharmaceuticals Inc
-
Figure Revenue and Market Share Analysis of Regeneron Pharmaceuticals Inc
-
Table Product and Service Introduction of Regeneron Pharmaceuticals Inc
-
Table Company Profile and Development Status of Bayer AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG
-
Figure Sales and Growth Rate Analysis of Bayer AG
-
Figure Revenue and Market Share Analysis of Bayer AG
-
Table Product and Service Introduction of Bayer AG
-
Table Company Profile and Development Status of Pfizer Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc
-
Figure Sales and Growth Rate Analysis of Pfizer Inc
-
Figure Revenue and Market Share Analysis of Pfizer Inc
-
Table Product and Service Introduction of Pfizer Inc
-
Table Company Profile and Development Status of Gilead Sciences Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Sciences Inc
-
Figure Sales and Growth Rate Analysis of Gilead Sciences Inc
-
Figure Revenue and Market Share Analysis of Gilead Sciences Inc
-
Table Product and Service Introduction of Gilead Sciences Inc
-

Chinese